|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/06 | |
| A61K 38/15 | |||
| A61K 47/06 | |||
| A61K 47/14 | |||
| A61K 9/00 | |||
| A61P 17/00 |
| (11) | Patento numeris | 2699231 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12723241.1 |
| Europos patento paraiškos padavimo data | 2012-04-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-02-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/051946 |
| Data | 2012-04-18 |
| (87) | Numeris | WO 2012/143868 |
| Data | 2012-10-26 |
| (30) | Numeris | Data | Šalis |
| 201161477297 P | 2011-04-20 | US |
| (72) |
HAUG, Claire, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE |
| SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE |